tiprankstipranks
Advertisement
Advertisement

Chaoju Eye Care Signs Connected Tenancy Deals for New Premises

Story Highlights
  • Chaoju Eye Care’s subsidiaries agreed five-year leases for three premises with related parties Haohui and Tongde.
  • The connected tenancy deals trigger reporting and announcement duties but avoid independent shareholder approval under listing rules.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Chaoju Eye Care Signs Connected Tenancy Deals for New Premises

Meet Samuel – Your Personal Investing Prophet

Chaoju Eye Care Holdings Ltd. ( (HK:2219) ) has issued an update.

Chaoju Eye Care Holdings Limited has entered into a series of tenancy agreements under which its subsidiaries Chifeng Hospital and Chifeng Optical will lease three premises from Haohui and Tongde for five-year terms starting 6 May 2026. The leases, which will result in recognition of right-of-use assets under IFRS 16, are structured as connected transactions because the counterparties are associates of a controlling shareholder’s family.

Under Hong Kong Listing Rules, the tenancy arrangements are treated as one-off connected transactions, with the aggregated right-of-use asset value exceeding 0.1% but remaining below the 5% threshold that would trigger independent shareholders’ approval. As a result, the deals are subject only to reporting and announcement requirements, streamlining compliance while allowing the group to secure operating premises without additional shareholder voting procedures.

More about Chaoju Eye Care Holdings Ltd.

Chaoju Eye Care Holdings Limited is a Cayman Islands-incorporated company listed in Hong Kong that operates in the eye care and ophthalmic medical services sector. Through subsidiaries such as Chifeng Hospital and Chifeng Optical, the group provides clinical ophthalmology services and related optical products to patients in mainland China.

Average Trading Volume: 458,733

Technical Sentiment Signal: Buy

Current Market Cap: HK$2.16B

For a thorough assessment of 2219 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1